selenocysteine and Prostatic Neoplasms

selenocysteine has been researched along with Prostatic Neoplasms in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (43.75)	29.6817
2010's	7 (43.75)	24.3611
2020's	2 (12.50)	2.80

Authors

Authors	Studies
Bosland, MC; Deng, Y; Lü, J; Schlicht, MJ	1
Bera, S; Diamond, AM	1
Dong, Y; Guo, Y; Liang, Z; Liu, X; Liu, Y; Lu, L; Sun, Y; Tian, Y; Zhang, H; Zhao, X	1
Gao, AC; Nadiminty, N	1
Bonorden, MJ; Cleary, MP; Hu, H; Lee, HJ; Li, GX; Liao, JD; Lü, J; Wang, L; Zhang, Y	1
Buntinx, F; Goossens, ME; Zeegers, MP	1
Canene-Adams, K; Diamond, AM; Erdman, JW; Ford, NA; Lindshield, BL; Wallig, MA	1
Anderson, LB; Lü, J; Wang, L; Witthuhn, B; Xu, Y; Zhang, J	1
Dong, Y; Gao, L; Gao, R; Liu, X; Zhang, H; Zhao, L; Zhao, X; Zhao, Y	1
Cleary, MP; Liao, JD; Lü, J; Nkhata, K; Quealy, E; Wang, L; Zhang, J; Zhang, Y	1
Anderson, LB; Li, G; Lü, J; Wang, L; Witthuhn, B; Xu, Y; Zhang, J	1
Christensen, MJ; Eggett, DL; Lephart, ED; Nakken, HL; Quiner, TE; Urie, PM	1
Conklin, D; Millar, RP; Morgan, K; Ott, TR; Pawson, AJ; Sellar, R	1
Dong, Y; Gao, AC; Ip, C; Lee, SO; Nadiminty, N; Trump, DL; Yeon Chun, J	1
Azrak, RG; Foster, BA; Frank, CL; Li, F; Ling, X; Rustum, YM; Slocum, HK	1
Bosello, V; Bulato, C; Maiorino, M; Ursini, F	1

Reviews

2 review(s) available for selenocysteine and Prostatic Neoplasms

Article	Year
Role of SELENBP1 and SELENOF in prostate cancer bioenergetics. Archives of biochemistry and biophysics, 2022, 12-15, Volume: 732 Topics: Energy Metabolism; Humans; Male; Prostatic Neoplasms; Selenium; Selenium-Binding Proteins; Selenocysteine; Selenoproteins	2022
Mechanisms of selenium chemoprevention and therapy in prostate cancer. Molecular nutrition & food research, 2008, Volume: 52, Issue:11 Topics: Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Humans; Male; Prostatic Neoplasms; Selenium; Selenocysteine; Selenomethionine	2008

Trials

1 trial(s) available for selenocysteine and Prostatic Neoplasms

Article	Year
Effect of Dietary Methylseleninic Acid and Se-Methylselenocysteine on Carcinogen-Induced, Androgen-Promoted Prostate Carcinogenesis in Rats. Nutrition and cancer, 2022, Volume: 74, Issue:10 Topics: Androgens; Animals; Antioxidants; Carcinogenesis; Carcinogens; Diet; Disease Models, Animal; Humans; Male; Mice; Organoselenium Compounds; Prostate; Prostatic Neoplasms; Rats; Selenium; Selenocysteine; Selenomethionine	2022

Article

Year

Effect of Dietary Methylseleninic Acid and Se-Methylselenocysteine on Carcinogen-Induced, Androgen-Promoted Prostate Carcinogenesis in Rats.

Nutrition and cancer, 2022, Volume: 74, Issue:10

Topics: Androgens; Animals; Antioxidants; Carcinogenesis; Carcinogens; Diet; Disease Models, Animal; Humans; Male; Mice; Organoselenium Compounds; Prostate; Prostatic Neoplasms; Rats; Selenium; Selenocysteine; Selenomethionine

2022

Other Studies

13 other study(ies) available for selenocysteine and Prostatic Neoplasms

Article	Year
Methylselenocysteine preventing castration-resistant progression of prostate cancer. The Prostate, 2015, Jun-15, Volume: 75, Issue:9 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Progression; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Random Allocation; Receptors, Androgen; Selenocysteine; Xenograft Model Antitumor Assays	2015
Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer prevention research (Philadelphia, Pa.), 2009, Volume: 2, Issue:5 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cysteine; Enzyme-Linked Immunosorbent Assay; In Situ Nick-End Labeling; Insulin-Like Growth Factor I; Male; Mice; Mice, Transgenic; Organoselenium Compounds; Prostatic Neoplasms; Selenocysteine; Selenomethionine	2009
Re: Selenium and vitamin E: interesting biology and dashed hope. Journal of the National Cancer Institute, 2009, Oct-07, Volume: 101, Issue:19 Topics: Animals; Anticarcinogenic Agents; Humans; Male; Meta-Analysis as Topic; Prostatic Neoplasms; Selenium; Selenocysteine; Selenomethionine; Vitamin E	2009
Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors. PloS one, 2010, Apr-29, Volume: 5, Issue:4 Topics: Androgens; Animals; Carotenoids; Cell Proliferation; Cysteine; Lycopene; Male; Neoplasm Transplantation; Organoselenium Compounds; Prostatic Neoplasms; Rats; Selenium; Selenocysteine; Tumor Burden; Vitamin E	2010
Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model. Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:8 Topics: Adenocarcinoma; Animals; Biomarkers, Pharmacological; Biomarkers, Tumor; Cysteine; Disease Models, Animal; Male; Metabolome; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Biological; Organoselenium Compounds; Prostatic Neoplasms; Proteomics; Selenium Compounds; Selenocysteine; Selenomethionine	2010
Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition. BMC cancer, 2010, Aug-10, Volume: 10 Topics: Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cysteine; Down-Regulation; Drug Synergism; Gene Silencing; Humans; Immunoenzyme Techniques; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; Organoselenium Compounds; Prognosis; Prostatic Neoplasms; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selenocysteine; Survival Rate; Survivin	2010
Lobe-specific lineages of carcinogenesis in the transgenic adenocarcinoma of mouse prostate and their responses to chemopreventive selenium. The Prostate, 2011, Sep-15, Volume: 71, Issue:13 Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Cell Lineage; Cysteine; Disease Models, Animal; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Metastasis; Organoselenium Compounds; Prostatic Neoplasms; Proteomics; Selenocysteine; Seminal Vesicles	2011
Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds. Nutrition and cancer, 2011, Volume: 63, Issue:5 Topics: Animals; Anticarcinogenic Agents; Cysteine; Gene Expression Profiling; Gene Expression Regulation; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Organoselenium Compounds; Prostate; Prostatic Neoplasms; Protein Biosynthesis; Proteomics; RNA, Messenger; Selenium Compounds; Selenocysteine; Selenomethionine; Sodium Selenite; Xenograft Model Antitumor Assays	2011
Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer. The Prostate, 2013, Volume: 73, Issue:9 Topics: Animals; Cell Transformation, Neoplastic; Diet; Dietary Supplements; Disease Models, Animal; Female; Gene Expression; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prostatic Neoplasms; Receptors, Androgen; Selenocysteine; Soy Foods	2013
A transcriptionally active human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the antisense orientation on chromosome 1q.12. Endocrinology, 2003, Volume: 144, Issue:2 Topics: Adenoma; Alternative Splicing; Amino Acid Sequence; Animals; Blotting, Northern; Breast Neoplasms; Callithrix; Choriocarcinoma; Chromosomes, Human, Pair 1; DNA, Antisense; Endometrial Neoplasms; Evolution, Molecular; Female; Humans; Jurkat Cells; Male; Molecular Sequence Data; Neuroblastoma; Nucleic Acid Conformation; Open Reading Frames; Phylogeny; Pituitary Neoplasms; Promoter Regions, Genetic; Prostatic Neoplasms; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; Selenocysteine; Sequence Homology, Nucleic Acid; Transcriptional Activation	2003
Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). The Prostate, 2006, Jul-01, Volume: 66, Issue:10 Topics: Animals; Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Cysteine; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Organoselenium Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Selenium; Selenocysteine; Xenograft Model Antitumor Assays	2006
The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells. Molecular cancer therapeutics, 2006, Volume: 5, Issue:10 Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cysteine; Docetaxel; Down-Regulation; Drug Synergism; Enzyme Activation; Inhibitor of Apoptosis Proteins; Male; Mice; Microtubule-Associated Proteins; Neoplasm Proteins; Organoselenium Compounds; Prostatic Neoplasms; Selenocysteine; Survivin; Taxoids	2006
Effect of mercury on selenium utilization and selenoperoxidase activity in LNCaP cells. Free radical biology & medicine, 2007, Jan-01, Volume: 42, Issue:1 Topics: Humans; Hydrogen Peroxide; Male; Mercury; Prostatic Neoplasms; Selenium; Selenocysteine; Selenomethionine; Selenoproteins; Sodium Selenite; Tumor Cells, Cultured	2007